Webinars

MAR 26, 2020 9:00 AM PDT

Cutting Edge Viral and Non-Viral Delivery Platforms for T-Cell Engineering and Beyond

Sponsored by: Thermo Fisher Scientific - Invitrogen

C.E. Credits: P.A.C.E. CE ｜ Florida CE

+25pts

Speaker

Namritha Ravinder
Senior R&D manager, Thermo Fisher Scientific
Biography
Namritha Ravinder, is a Senior R&D manager at Thermo Fisher Scientific in Carlsbad, California. Dr. Ravinder and her team is focused on developing platforms and workflows for Cell and Gene therapy applications including gene delivery and viral vector systems. Prior to her current role she lead product development initiatives around mammalian genome editing and functional genomics screening as well as helped establish a variety of custom service offerings within Thermo Fisher Scientific including cDNA library generation, virus production, gene expression profiling and custom RNAi screening tools. She earned her Doctorate in Biotechnology from University of Alabama in Huntsville followed by a Postdoctoral research at Children's Hospital in Los Angeles in HIV Virology.
https://www.linkedin.com/in/namritha-ravinder-94597559

Abstract

DATE: March 26, 2020

TIME: 9:00am PST, 12:00pm EST

Growing demand for precision therapy and the recent successes with CAR-T cells for cancer treatment has put the spot light on Cell and Gene Therapy Applications. However, the difficulty of delivering relevant payloads into immune and other challenging cells remains to be a major bottle neck to rapid advancement from bench to clinic. Most studies have been focused on using viruses to engineer T cells. At the same time due to safety concerns with viral vectors there is also lot of demand and investment in non-viral based methods to maximize gene editing efficiencies in immune cells especially to meet increasing demand for developing allogeneic immune cell therapies.

This talk will cover recent advancements we have made in delivery tools for genome editing, immune cell engineering and in vivo delivery applications. More specifically we will be addressing the following 4 focus areas.

Nucleic acid delivery solutions for hard-to-transfect primary & immune cell
Delivery of genome editing tools like CRISPR-Cas9 with electroporation or transfection reagents
Scalable and high yield Lentivirus production platform for cell and gene therapy applications
In vivo delivery of mRNA and siRNA with Invivofectamine™ reagents.

Learning Objectives:

Understand the difference between viral and non-viral delivery methods
Discover new technologies for T-Cell Engineering

Webinars will be available for unlimited on-demand viewing after live event.

LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

Show Resources

You May Also Like

JAN 23, 2020 9:00 AM PST

C.E. CREDITS

JAN 23, 2020 9:00 AM PST

A Workflow for Knock-in Genome Editing: Simplified

DATE: January 23, 2020 TIME: 9:00am PST, 12:00pm EST...

APR 07, 2020 8:00 AM PDT

C.E. CREDITS

APR 07, 2020 8:00 AM PDT

Best Practice Criteria for Pluripotent Stem Cell Lines

DATE: April 7, 2020 TIME: 8:00am PT, 11:00am ET This webinar sets out to establish why quality control is key to robust, reliable, reproducible science. We will look at best practice criteri...

MAR 03, 2020 9:00 AM JST

C.E. CREDITS

MAR 03, 2020 9:00 AM JST

CTS StemPro™ HSC Expansion Medium for Cell and Gene Therapies

DATE: March 3, 2020 TIME: 9:00am JST A major limitation in the ex vivo expansion of harvested human hematopoietic stem-progenitor cells (HSPCs) is the rapid differentiation of HSPCs at the e...

FEB 25, 2020 9:00 AM PST

C.E. CREDITS

FEB 25, 2020 9:00 AM PST

CAR-T Generation for Identity, Purity and Potency Assay Testing

Learn about how to generate a small scale CAR-T workflow using ThermoFisher products See detailed characterization tools that can be utilized and applied in a CAR-T workflow...

DEC 10, 2019 9:00 AM PST

C.E. CREDITS

DEC 10, 2019 9:00 AM PST

CTS StemPro™ HSC Expansion Medium for Cell and Gene Therapies

DATE: December 10, 2019TIME: 9:00am PST, 12:00pm EST A major limitation in the ex vivo expansion of harvested human hematopoietic stem-progenitor cells (HSPCs) is the rapid dif...

FEB 26, 2020 9:00 AM PST

C.E. CREDITS

FEB 26, 2020 9:00 AM PST

The use of 3D Models in Hepatic Biology

DATE: February 26, 2020 TIME: 9:00am PST 3D cell culture and analysis and the study of organoids and spheroids are becoming more prevalent as a research method in publications as traditional...

Loading Comments...

Show Resources

Attendees

See more